RBC Capital Reiterates Outperform on HCA Healthcare, Maintains $435 Price Target

Benzinga · 3d ago
RBC Capital analyst Ben Hendrix reiterates HCA Healthcare (NYSE:HCA) with a Outperform and maintains $435 price target.